View Poll Results: Did you buy shares ?

1110. You may not vote on this poll
  • Yes, I'm acting now !

    694 62.52%
  • No

    416 37.48%
  1. Shanerredflag's Avatar
    The ranking of Passport is now out of 20 in the Amazon's best seller list under the unlocked cell phone category. Is anyone concerned about it?
    Which country are you looking from? Still ranked fourth here under unlocked new releases, and, number 1,2 and 3 by customer review (black, red and white version).?

    Passport'n stuff all day long.
    12-08-14 07:21 AM
  2. sidhuk's Avatar
    One of the biggest blackberry hater has change of tone?

    At 9 minute mark.
    Posted using BlackBerry passport.
    Last edited by sidhuk; 12-08-14 at 07:48 AM.
    bungaboy, Mr BBRY, jxnb and 3 others like this.
    12-08-14 07:33 AM
  3. bspence87's Avatar
    Seems like the market was watching 60 minutes last night.
    Hopefully we can hold the gains after premarket!

    *beer* to a good week! it too early?

    Posted via CB10
    12-08-14 07:40 AM
  4. bungaboy's Avatar
    The ranking of Passport is now out of 20 in the Amazon's best seller list under the unlocked cell phone category. Is anyone concerned about it?
    sidhuk, Corbu, W Hoa and 1 others like this.
    12-08-14 07:41 AM
  5. plasmid_boy's Avatar
    BlackBerry and NantHealth Launch Breakthrough NantOmics Cancer Genome Browser | Business Wire

    This is some really fascinating stuff! I loved the 60 Minutes piece about Dr. Soon-Shiong and think it brings potential for BlackBerry's involvement.

    Was anyone able to dig into last quarter's financials and determine how much BlackBerry's minority stake in NantHealth is? With their upcoming IPO and current valuation of ~$7B, could the success of NantHealth be significant enough drive growth for BlackBerry?

    It's all really interesting and exciting stuff and I can't help but to draw the coincidence to what used to be OT in this thread (biotechnology) is now N.O.T. (not off topic)! I found myself understanding Dr Shiongs medical terminology because of the background I'm learning here. Even Mr. Lazaridis himself is working in a not too distant tech field (Quantum Computing). I wouldn't mind seeing him involved in the future too. Okay, I'll ease off with the astrological alignment cr*p. I forget that we are talking about a dead company who will be going belly up any day now.

    Have a great week guys! Looking forward to the end of the year run up!
    I was happy to see that they weren't some pie in the sky crazy ideas. What they are trying to do are logical and based on decades of research results done by various scientists around the world. Too early to tell if injecting cultured T-cells or sorting out cancer cells would be effective treatments for cancer, but they are logical strategies IMO and hold realistic promise. The genomic server would be useful. This is already being done, but over various different government-run servers and require quite a bit of skills that most doctors typically don't have, so a specialized and unified browser accessible with a BlackBerry phone is a significant step forward. Overall, I didn't see any new or novel ideas, but I liked what I saw.

    Posted via CB10
    12-08-14 07:45 AM
  6. Corbu's Avatar
    lech31, bbjdog, jxnb and 10 others like this.
    12-08-14 08:12 AM
  7. Corbu's Avatar
    Here Is What '60 Minutes' Didn't Tell You About The Billionaire Who Is Trying To Disrupt Cancer Care - Forbes

    CBS’s fabled newsmagazine show “60 Minutes” just spent 12 minutes showing viewers everything there is to love about Patrick Soon-Shiong, the doctor who is the richest man in L.A. and, actually, the richest physician in the world.

    As I wrote in a Forbes cover story in September, Soon-Shiong is rolling out a series of companies that represent a $1 billion-plus effort to fight cancer in new ways. This includes buying DNA sequencers to unravel the DNA of cancer patients, not in a clinical trial but as standard practice, at an unprecedented scale.

    “I’m incredibly encouraged to say that we are on the path,” Soon-Shiong told 60 Minutes’ Sanjay Gupta. “And the technology to actually do all these things is not just hypothetical.”

    Many experts in the cancer field would wholeheartedly agree. And Soon-Shiong, with his vast wealth and business sense could play an outsize role in making that happen. But there are caveats to his story that Gupta and 60 Minutes ignored, and they’re worth listing here.

    This is all part of a for-profit company

    60 Minutes just skates past saying that it talked to Soon-Shiong at “his company.” That makes it sound a bit like Soon-Shiong is a dispassionate scientist.

    He’s actually a CEO who wants to convince investors to buy his shares. His net worth has been rising – it’s currently $13.3 billion, $2.3 billion more than the figure 60 Minutes used — precisely because the value of his companies has been going up as more investors come in. In September we valued his umbrella company, NantWorks, at $7.7 billion.

    Last Thursday, Soon-Shiong said at the Forbes Healthcare Summit that he plans an initial public offering for one of his companies, NantHealth, sometime in 2015. He also said that he plans to put a lot of his NantHealth shares into a charitable trust for funding research against cancer.

    But as an entrepreneur planning an IPO, he has every reason to want to talk up his project. His investors, including BlackRock BLK +1.02%, Verizon, Celgene CELG +0.5%, and Blackberry, would expect no less.

    Many of Soon-Shiong’s “radical” ideas are conventional

    When Soon-Shiong says: “A cancer is not what people think, cells growing. Cancer is actually the inability of the cells to die,” Sanjay Gupta seems surprised. The same thing happens when Soon-Shiong says that cancers should be treated based on their genetic mutations, not where they are in the body.

    This idea isn’t some out-there statement; it’s basically conventional wisdom. Earlier this year I talked to a cancer patient who had select genes in her bowel tumor sequenced – and as a result took a lung cancer drug that made it shrink away.

    Everyone is looking to use DNA sequencing to better pick cancer drugs. And in some ways, Soon-Shiong is an odd person to pick as a spokesperson for this, because he’s just getting started. When I visited him in August, the DNA sequencers he bought from Illumina of San Diego were still in boxes. During Gupta’s October visit, they were being run through their paces – not being used on patients. Soon-Shiong’s cancer-gene-analysis factory is just getting started. But it is also true that he is planning to implement these efforts on a scale that few else are.

    He’s not doing it alone

    One of the most dramatic moments in the “60 Minutes” piece comes from a patient named David Roy, a pancreatic cancer patient who, we’re told, got into a clinical trial using the drug Abraxane, which Soon-Shiong invented and which helped make his fortune, thanks to having sat on a plane with the doctor years ago.

    Now Roy is in a trial of a new drug, which uses the immune system to attack tumors. And Soon-Shiong waxes eloquent about the potential of such treatments. Something the story doesn’t emphasize strongly enough: of all the amazing areas of cancer therapy that Soon-Shiong is working in, he is not working in the immune-derived cancer treatments that are currently showing amazing results.

    He can be misleading

    Sometimes Soon-Shiong makes statements that can be, at best, misleading. For instance, last year at our annual Healthcare Summit he stated that NantHealth could analyze a genome in 47 seconds, compared to 11 weeks at other genomics centers.

    This statement turned out to be problematic. It came from the company’s ability to use supercomputers to analyze many genomes at once and, on average, it completed one every 47 seconds. But that’s a little like expecting McDonald’s to give you 800 Happy Meals the moment you pull up to the drive-through because McDonald’s serves 800 burgers a second worldwide.

    But the number still sticks around – it’s prominently displayed on NantHealth’s website. Some of Soon-Shiong’s claims make it into peer-reviewed journals, but many of them don’t. It can be hard to know which parts are true and which aren’t.

    I think cancer patients and investors alike should be aware of those caveats. But let me say something else: I looked long and hard at Soon-Shiong’s efforts, and I came away optimistic that something real might come out of them. He really does have some amazing computer scientists on his payroll. And he really can move genetic data around very, very fast. Those are real advantages, and it could be enough for him to build an important company around. But we should be careful with myth-making. None of this will happen overnight.

    Soon-Shiong may be a genius, but geniuses can be catastrophically wrong. That’s why we demand proof. When it comes to Soon-Shiong’s new efforts, we’re still waiting.
    early2bed, Mr BBRY, jxnb and 9 others like this.
    12-08-14 08:23 AM
  8. CDM76's Avatar
    The ranking of Passport is now out of 20 in the Amazon's best seller list under the unlocked cell phone category. Is anyone concerned about it?
    Not I.

    Posted via CB10
    bungaboy and Soumaila Somtore like this.
    12-08-14 08:54 AM
  9. bbjdog's Avatar
    More reading material.

    BlackBerry and NantHealth Launch Breakthrough NantOmics Cancer Genome Browser (ccnm)
    WATERLOO, ONTARIO and CULVER CITY, CALIFORNIA--(Marketwired - Dec. 8, 2014) - BlackBerry Limited (NASDAQ:BBRY) (TSX:BB), a global leader in mobile communications, and NantHealth, a cloud-based information technology provider combining science and big data to transform healthcare, today announced the first secure clinical genome browser that gives doctors unprecedented access to patients' genetic data on the BlackBerry Passport smartphone - the NantOmics Cancer Genome Browser™.
    The NantOmics Cancer Genome Browser platform on the BlackBerry Passport enables deep, interactive reporting on genomics data for physicians and other treatment providers in clinical settings - for example, giving oncologists a powerful view into the individual genetic alternations that make each patient's disease unique and highlighting relevant treatment options. The BlackBerry Passport's large high resolution screen enables clinicians to view a patient's chromosome at an individual base-pair level. It is the first in a series of innovative offerings being developed jointly by BlackBerry and NantHealth for use by healthcare professionals.
    "BlackBerry's partnership with NantHealth illustrates how the mobile security and collaboration technology we are known for can be reimagined to create revolutionary applications across a variety of industries," said John Chen, Executive Chairman and CEO, BlackBerry. "BlackBerry technology has proven itself secure, reliable and powerful enough to be counted on in life-and-death situations. Its innovative form and functionality make BlackBerry Passport an ideal addition to a doctor's medical kit."
    "The proprietary NantOmics Cancer Genome Browser enables clinicians for the first time to investigate a tumor genome from the full three billion bases down to the single-base level in real-time, thanks to the power of the NantOmics supercomputing infrastructure," said Patrick Soon-Shiong, M.D., founder and CEO of NantHealth. "This integrates with NantHealth's treatment recommendation engine, Eviti, to personalize treatment protocols to individual patients based on their genomic signature."
    Powered by BlackBerry's mobile security infrastructure, the NantOmics Cancer Genome Browser is fully encrypted to allow deployment in a HIPAA-secured environment, enabling clinicians to securely access patient data as soon as it's available, wherever they are. BlackBerry's recently launched BES12 cross-platform EMM solution will enable hospital IT administrators to easily deploy the application to a clinician's BlackBerry Passport smartphone and ensures that the application data is fully secure end-to-end.
    "BlackBerry already powers many of the diagnostic machines clinicians rely heavily upon so it makes sense to tie those devices directly to a BlackBerry smartphone," said Soon-Shiong. "NantHealth has quietly built the unique capability of placing a super-computer into the doctor's hand at point of care and in time of need. Now with BlackBerry's partnership and through the power of the cloud and secure networks, the reality is we are now able to put dozens of supercomputers, through mobile devices, into doctor's hands on a global basis. Our goal is to extend this unique capability from doctor to patient, thereby establishing patient empowered 21st century health."
    The NantOmics Cancer Genome Browser will be demonstrated at the Consumer Electronics Show (CES) in January and will be preloaded on some BlackBerry Passport devices and available to the professional community in early 2015.
    About BlackBerry
    A global leader in mobile communications, BlackBerry revolutionized the mobile industry when it was introduced in 1999. Today, BlackBerry aims to inspire the success of our millions of customers around the world by continuously pushing the boundaries of mobile experiences. Founded in 1984 and based in Waterloo, Ontario, BlackBerry operates offices in North America, Europe, Middle East and Africa, Asia Pacific and Latin America. The Company trades under the ticker symbols "BB" on the Toronto Stock Exchange and "BBRY" on the NASDAQ. For more information, visit Cell Phones, Smartphones & Mobile Phones from
    About NantOmics
    NantOmics is a leading medical diagnostic company dedicated to providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular diagnostics company to pioneer an integrated approach to unearthing the genomic and proteomic variances that initiate and drive cancer, by analyzing both normal and tumor cells from the same patient and following identified variances through from DNA to RNA to protein to drug. NantOmics has a highly scalable cloud-based infrastructure capable of storing and processing thousands of genomes a day, computing genomic variances in near real-time, and correlating proteomic pathway analysis with quantitative multi-plexed protein expression analysis from the same micro-dissected tumor sample used for genomic analysis. For more information visit NantOmics.
    About NantHealth
    NantHealth, a member of the NantWorks ecosystem of companies, is a transformational healthcare cloud-based IT company converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care, in the time of need, anywhere, anytime. NantHealth works to transform clinical delivery with actionable clinical intelligence at the moment of decision, enabling clinical discovery through real-time machine learning systems. The company's technology empowers physicians, patients, payers and researchers to transcend the traditional barriers of today's healthcare system. By converging molecular science, near real-time patient signal monitoring, computer science and big data technology, the NantHealth Clinical Operating System (cOS) platform empowers physicians, patients, and payers to coordinate best care, monitor outcomes and control cost in real time. This is the first system of its kind in healthcare, enabling 21st century coordinated care at a lower cost, enabling value-based population health management at a single patient level and at the population at large. For more information please visit HOME - NANTHEALTH.

    Contact Information:
    Media Contact:
    BlackBerry Media Relations
    (519) 888-7465 x77273
    12-08-14 08:56 AM
  10. CDM76's Avatar
    Less than 2 weeks to ER!!!

    Any guesses how many Passports sold in this ER eligible time-period?

    Didn't someone post a link to some 66,000 Passports sold numbers?
    I REALLY hope you meant to add a zero to that number.

    Posted via CB10
    bbjdog and Soumaila Somtore like this.
    12-08-14 08:57 AM
  11. bbjdog's Avatar
    And more!

    BlackBerry, NantHealth launch cancer genome browser (Thomson Reuters)
    By Euan Rocha
    TORONTO, Dec 7 (Reuters) - BlackBerry Ltd and NantHealth, a healthcare-focused data provider, launched a secure cancer genome browser on Sunday, giving doctors the ability to access patients' genetic data on the BlackBerry Passport smartphone.
    Earlier this year, BlackBerry bought a minority stake in privately held NantHealth. The mobile technology company sees healthcare as one of the niche sectors in which it has an advantage, due to the heightened focus on patient privacy and BlackBerry's vast networks that can manage and secure data on mobile devices.
    The company said the cancer genome browser on the BlackBerry Passport enables deep, interactive reporting on genomics data for physicians. It gives oncologists a tool to view individual genetic alternations in a disease and allows them to highlight relevant treatment options.
    BlackBerry launched the square-screened Passport device in September, the oddly shaped device was fashioned in a sense to tailor to the needs of the physicians, with a wider screen that allows for better viewing of X-rays, scans and documents.
    "Our partnership with BlackBerry has really been able to create a scalable super-computer in the palm of the hands of the doctor," said Patrick Soon-Shiong, chief executive of NantHealth.
    BlackBerry Chief Executive John Chen said he expects this roll-out to get healthcare professionals interested in the Passport.
    The genome browser is fully encrypted to allow deployment to enable clinicians to securely access patient data as soon as it is available, wherever they are.
    The browser will be demonstrated at the Consumer Electronics Show (CES) in Las Vegas in January and it will be pre-loaded on BlackBerry Passport devices and available to the professional community in early 2015. The browser will also be available on certain other devices running on rival platforms, but secured by BlackBerry's network.
    California-based NantHealth, whose cloud-based platform already connects thousands of medical devices in hospitals, was founded by Soon-Shiong, a surgeon and businessman, who made billions of dollars selling his two former companies, American Pharmaceutical Partners and Abraxis BioScience.
    Soon-Shiong said the BlackBerry and NantHealth will continue to collaborate on software and hardware, and he said that the two are already working on a new device that will revolutionize the transport of big data sets. Details on this will be outlined early next year. (Editing by Muralikumar Anantharaman)
    jxnb, Mr BBRY, morganplus8 and 3 others like this.
    12-08-14 08:57 AM
  12. Corbu's Avatar
    12-08-14 09:01 AM
  13. bbjdog's Avatar
    Information purpose only! Friday four bullish signals had been triggered. Lets keep the good news going for Blackberry.

    BlackBerry Ltd (BBRY:NASDAQ)

    MACD *W -- Intermediate-Term Bullish
    BlackBerry Ltd (BBRY:NASDAQ)

    Momentum *W -- Short-Term Bullish
    BlackBerry Ltd (BBRY:NASDAQ)

    Williams %R *W -- Short-Term Bullish
    BlackBerry Ltd (BBRY:NASDAQ)

    Williams %R -- Short-Term Bullish
    12-08-14 09:11 AM
  14. Shanerredflag's Avatar
    Now back to our regular scheduled programing.

    Passport'n stuff all day long.
    12-08-14 09:41 AM
  15. ibpluto's Avatar
    Seems to be rattling around right at resistance.....

    CB10'n it....via da Z30
    bungaboy likes this.
    12-08-14 10:01 AM
  16. randall2580's Avatar
    Attachment 319375

    Take it as a so-far so-good?

    Over 5 million BES12 downloads and 4.1 stars. Would be nice to see the same info for the iOS version.

    Posted via CB10
    The BBRY Café.  [Formerly: I support BBRY and I buy shares]-img_0002.jpg

    That's for "all versions". For "current version" it says: "We have not received enough ratings to display an average for this app."
    dusdal likes this.
    12-08-14 10:20 AM
  17. bspence87's Avatar
    Click image for larger version. 

Name:	IMG_0002.jpg 
Views:	925 
Size:	88.4 KB 
ID:	319441

    That's for "all versions". For "current version" it says: "We have not received enough ratings to display an average for this app."
    Still! There were 5.1 million users at BES12 launch. Now there are that many on Android alone. Add iOS and BlackBerry, which I think would still have the most and it's looking pretty good.

    Just be aware that these are downloads, and not subscriptions. The comments would indicate that a rather large percentage of the downloads are from people looking for BBM.

    Posted via CB10
    CDM76, bungaboy and dusdal like this.
    12-08-14 10:40 AM
  18. CDM76's Avatar

    Just be aware that these are downloads, and not subscriptions. The comments would indicate that a rather large percentage of the downloads are from people looking for BBM.

    Posted via CB10
    Just goes to show the absolute stupudity and laziness (take 30 seconds to read the description) of people these days. Absolutely pathetic.

    Posted via CB10
    12-08-14 10:50 AM
  19. bspence87's Avatar
    Speaking of which, does anyone want to take a guess at ER numbers?
    More specifically Revenues, Profit, BB10 sales and BES licenses.

    If I may, I'll guess:
    Revenues at $1.12 Billion (thanks to Passport's high margins)
    Non-GAAP profit of $180 million (slightly higher OpEx from Passport launch, marketing)
    BB10 sales of 3.2 million devices (thanks to Passport and Black Friday)
    BES licenses of 7.4 million (adoption seems to be accelerating, based on the last three releases)

    All of my numbers are higher than expected, mostly because I believe that the Passport will make a HUGE difference on the bottom line. As well, people don't seem to recognise how good BES12 is. Big accounts knew what was coming long before the official release.

    Posted via CB10
    12-08-14 10:59 AM
  20. Munx's Avatar
    Concerned about BlackBerry's potential tablet entry. Tablet sales are shrinking as large phones eat their lunch. Even the mighty i-tablet sales are contracting. I really don't like the idea.

    Posted via CB10
    12-08-14 11:09 AM
  21. sidhuk's Avatar
    Concerned about BlackBerry's potential tablet entry. Tablet sales are shrinking as large phones eat their lunch. Even the mighty i-tablet sales are contracting. I really don't like the idea.

    Posted via CB10
    CEO has said that he won't just release any tablet. And that Nanthealth didn't say tablet. It said a device which would revolutionize the viewing of large data.

    Posted using BlackBerry passport.
    12-08-14 11:28 AM
  22. lcjr's Avatar
    I'm thinking when Blackberry comes out with a tablet type device it will be something small/compact (slightly larger than the Passport) and meant for business types. Just my thoughts anyway.
    12-08-14 11:32 AM
  23. Munx's Avatar
    Re tablet: when speaking at the Technologies That Matter forum in Hong Kong, Chen said that he agreed (with an attendee) that it would be ideal to have a device with the convenience of a keyboard but the screen real estate of a touch device. He said they are working on it. I am recalling from memory here so I don't have an exact quote.

    This will be the device that they reveal in Q1. Given his frequent reference to entering the tablet market with a unique offering, I think we will see a tablet with some sort of innovative keyboard.

    I hate seeing us enter a shrinking category - no matter how innovative the product. However this is Chen and he doesn't make many mistakes.

    Posted via CB10
    georg4BB, sidhuk, bungaboy and 5 others like this.
    12-08-14 12:05 PM
  24. bbjdog's Avatar
    I truly hope they are working on the MJ11 concept cell phone. This phone would answer all our questions. Then again it is only a concept that might never come to fruition.

    Posted via CB10
    12-08-14 12:18 PM
  25. Corbu's Avatar
    12-08-14 01:11 PM
107,440 ... 30153016301730183019 ...

Similar Threads

  1. Does the Motion have the paratek antenna?
    By Steve Pogue in forum BlackBerry Motion
    Replies: 15
    Last Post: 01-13-18, 01:33 AM
  2. Replies: 11
    Last Post: 11-24-17, 12:06 AM
  3. Will Hub+ work on the new Google Pixelbook?
    By danosman in forum BlackBerry HUB+ Suite
    Replies: 3
    Last Post: 11-02-17, 08:42 AM
  4. BlackBerry highlights the impact of KRACK vulnerability on BlackBerry products
    By CrackBerry News in forum News Discussion
    Replies: 0
    Last Post: 10-30-17, 04:10 PM
  5. Hub and Viber notifications broken
    By LyoobaBerry in forum BlackBerry HUB+ Suite
    Replies: 0
    Last Post: 10-30-17, 03:54 PM

Tags for this Thread